GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Qiagen NV (LTS:0RLT) » Definitions » Total Long-Term Liabilities

Qiagen NV (LTS:0RLT) Total Long-Term Liabilities : €1,452 Mil (As of Sep. 2024)


View and export this data going back to 2008. Start your Free Trial

What is Qiagen NV Total Long-Term Liabilities?

Total Long-Term Liabilities includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities. Qiagen NV's Total Long-Term Liabilities for the quarter that ended in Sep. 2024 was €1,452 Mil.

Qiagen NV Total Long-Term Liabilities Historical Data

The historical data trend for Qiagen NV's Total Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Qiagen NV Total Long-Term Liabilities Chart

Qiagen NV Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Long-Term Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,572.91 2,054.68 1,356.65 1,743.19 1,126.20

Qiagen NV Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Total Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,582.24 1,126.20 1,086.64 1,063.21 1,452.08

Qiagen NV Total Long-Term Liabilities Calculation

Total Long-Term Liabilities represents the obiligation that incurred as part of normal operations that is expected to be repaid beyond the following twelve months or one business cycle, excluding minority interest. It includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities.

Qiagen NV Total Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Qiagen NV's Total Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Qiagen NV Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Qiagen NV (LTS:0RLT) » Definitions » Total Long-Term Liabilities
Comparable Companies
EXAS CRL MEDP RDNT RVTY GH SHC NEOG VCYT TWST TMO DHR XSWX:LONN A IQV IDXX MTD ILMN WAT NTRA
Traded in Other Exchanges
QGEN:USA 1QGEN:Italy QIAd:UK QIA:Germany QIA:Germany QIA:Germany QGE2:Austria
Address
Hulsterweg 82, Venlo, LI, NLD, 5912 PL
Website
https://www.qiagen.com
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2023 sales), followed by EMEA (32%), and the Asia-Pacific (16%).

Qiagen NV Headlines

No Headlines